amikacin has been researched along with Craniocerebral Trauma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botha, FJ; Parkin, DP; Seifart, HI; van der Bijl, P | 1 |
| Hamory, B; Ignatiadis, P; Sande, MA | 1 |
2 other study(ies) available for amikacin and Craniocerebral Trauma
| Article | Year |
|---|---|
Fluctuation of the volume of distribution of amikacin and its effect on once-daily dosage and clearance in a seriously ill patient.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Craniocerebral Trauma; Drug Monitoring; Extracellular Space; Fluid Therapy; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Time Factors; Tissue Distribution | 1996 |
Intrathecal amikacin administration. Use in the treatment of gentamicin-resistant Klebsiella pneumoniae meningitis.
Topics: Adult; Amikacin; Craniocerebral Trauma; Drug Resistance, Microbial; Gentamicins; Humans; Injections, Spinal; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis | 1976 |